Forgotten Radiation Therapy Revives Hope for Stubborn Osteoarthritis Pain

Forgotten Radiation Therapy Revives Hope for Stubborn Osteoarthritis Pain

Mitchell Wilson
Mitchell Wilson
2 Min.
An x-ray image displaying the bones and ligaments of a knee joint.

Forgotten Radiation Therapy Revives Hope for Stubborn Osteoarthritis Pain

A once-forgotten treatment for osteoarthritis is making a comeback in the U.S. Low-dose radiation therapy, first used in Germany over a century ago, now offers an alternative for patients who find little relief from medication but aren’t ready for surgery. The approach targets inflammation and pain with minimal side effects, filling a gap between drugs and joint replacement.

The method dates back to early 20th-century Germany, where doctors began exploring radiotherapy for arthritis symptoms in the 1920s and 1930s. After fading from use in the U.S. decades later, it has regained attention as a non-surgical option for stubborn osteoarthritis cases.

Today, the treatment focuses on shoulders, hands, knees, and feet—joints that are easy to target without risking nearby organs. It starts with a planning CT scan, followed by six short sessions over two to three weeks. Each appointment lasts under 10 minutes, with side effects limited to occasional skin irritation. Unlike cancer radiotherapy, which uses 40–80 units per session, osteoarthritis treatment delivers just 3 units. This keeps cancer risks extremely low while still reducing inflammation and pain. A recent trial found 70% of knee osteoarthritis patients reported less pain after treatment, compared to 40% in the placebo group. The therapy isn’t a cure, nor does it replace standard treatments like medication or surgery. Instead, it provides temporary relief for those stuck between ineffective drugs and operations they’re not yet prepared to undergo. It is not, however, used for rheumatoid or psoriatic arthritis.

Low-dose radiation therapy offers a middle-ground solution for osteoarthritis patients with limited options. Its brief sessions, low cancer risk, and proven pain reduction make it a practical choice for those delaying surgery. Clinics are now revisiting the treatment as demand grows for non-invasive alternatives.

Neueste Nachrichten